Ticker Scorecard - IMCR Basics Company: Immunocore Holdings IPO Date: February 5, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.5B Activated in VL: True Average Daily Range Avg Daily Range: $1.09 | 2.54% Avg Daily Range (30 D): $0.65 | 2.13% Avg Daily Range (90 D): $0.64 | 2.04% Institutional Daily Volume Avg Daily Volume: .25M Avg Daily Volume (30 D): .16M Avg Daily Volume (90 D): .21M Trade Size Avg Trade Size (Sh.): 74 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 69 Institutional Trades Total Inst.Trades: 1,501 Avg Inst. Trade: $1.81M Avg Inst. Trade (30 D): $1.73M Avg Inst. Trade (90 D): $1.82M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $1.68M Avg Closing Trade (30 D): $1.23M Avg Closing Trade (90 D): $1.05M Avg Closing Volume: 33.89K     News Jan 6, 2025 @ 12:00 PM Immunocore to present at the 43rd Annual J.P. Morg... Source: N/A Jan 2, 2025 @ 12:00 PM Immunocore appoints Travis Coy, previously a Non-E... Source: N/A Dec 23, 2024 @ 12:00 PM Immunocore announces first patient dosed in the Ph... Source: N/A Aug 20, 2024 @ 11:57 AM Cancer Immunotherapy Market Size Expected to Touch... Source: Prophecy Market Insights Jul 8, 2024 @ 5:02 PM Advanced Melanoma Clinical Trial Pipeline Analysis... Source: Delveinsight Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.95 $.17 $-.23 Diluted EPS $-.95 $.17 $-.23 Revenue $ 296.31M $ 80.25M $ 75.4M Gross Profit $ 293.71M $ 79.8M $ 73.69M Net Income / Loss $ -47.05M $ 8.74M $ -11.62M Operating Income / Loss $ -68.06M $ -8.5M $ -16.02M Cost of Revenue $ 2.6M $ .45M $ 1.71M Net Cash Flow $ 93.63M $ 32.78M $ -327.84M PE Ratio